NCT02559232

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With NVAF With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 247 (actual)
• Sponsor: Bayer · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a retrospective observational study to describe the sociodemographic and clinical characteristics of patients diagnosed with non-valvular atrial fibrillation (NVAF) at risk of stroke or systemic embolism, who at least three months ago changed their anticoagulant therapy, due to any clinical situation, and are currently on treatment with a direct oral anticoagulant (DOAC)

Conditions

• Stroke
• Prevention and Control
• Atrial Fibrillation

Interventions

Type	Name	Description
DRUG	Direct Oral Anticoagulant (DOAC)	Treatment pattern following the summary of product characteristics

Timeline

• Start date: 2015-09-01
• Primary completion: 2015-12-01
• Completion: 2016-03-01
• First posted: 2015-09-24
• Last updated: 2017-02-16

Locations

1 site across 1 country: Spain